These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 10484414)

  • 1. Neuropeptide Y contributes to innervation-dependent increase in I(Ca, L) via ventricular Y2 receptors.
    Protas L; Robinson RB
    Am J Physiol; 1999 Sep; 277(3):H940-6. PubMed ID: 10484414
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sympathetic innervation alters activation of pacemaker current (If) in rat ventricle.
    Qu J; Cohen IS; Robinson RB
    J Physiol; 2000 Aug; 526 Pt 3(Pt 3):561-9. PubMed ID: 10922008
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effects of neuropeptide Y on ion channels in ventricular myocytes].
    Zhao HC; Liu ZB; Feng QL; Cui XL; Zhang CM; Wu BW
    Sheng Li Xue Bao; 2006 Jun; 58(3):225-31. PubMed ID: 16786106
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuropeptide Y is an essential in vivo developmental regulator of cardiac ICa,L.
    Protas L; Barbuti A; Qu J; Rybin VO; Palmiter RD; Steinberg SF; Robinson RB
    Circ Res; 2003 Nov; 93(10):972-9. PubMed ID: 14525809
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuropeptide Y increases 4-aminopyridine-sensitive transient outward potassium current in rat ventricular myocytes.
    Heredia MP; Fernández-Velasco M; Benito G; Delgado C
    Br J Pharmacol; 2002 Apr; 135(7):1701-6. PubMed ID: 11934810
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The regulation of veratridine-stimulated electrogenic ion transport in mouse colon by neuropeptide Y (NPY), Y1 and Y2 receptors.
    Hyland NP; Cox HM
    Br J Pharmacol; 2005 Nov; 146(5):712-22. PubMed ID: 16100526
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuropeptide Y Y1 receptor mechanisms in sympathetic vascular control.
    Malmström RE
    Acta Physiol Scand Suppl; 1997; 636():1-55. PubMed ID: 9179320
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuropeptide Y: a novel angiogenic factor from the sympathetic nerves and endothelium.
    Zukowska-Grojec Z; Karwatowska-Prokopczuk E; Rose W; Rone J; Movafagh S; Ji H; Yeh Y; Chen WT; Kleinman HK; Grouzmann E; Grant DS
    Circ Res; 1998 Jul; 83(2):187-95. PubMed ID: 9686758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Y2 receptor expression and inhibition of voltage-dependent Ca2+ influx into rod bipolar cell terminals.
    D'Angelo I; Brecha NC
    Neuroscience; 2004; 125(4):1039-49. PubMed ID: 15120863
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuropeptide Y induces ischemic angiogenesis and restores function of ischemic skeletal muscles.
    Lee EW; Michalkiewicz M; Kitlinska J; Kalezic I; Switalska H; Yoo P; Sangkharat A; Ji H; Li L; Michalkiewicz T; Ljubisavljevic M; Johansson H; Grant DS; Zukowska Z
    J Clin Invest; 2003 Jun; 111(12):1853-62. PubMed ID: 12813021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuropeptide Y induced attenuation of catecholamine synthesis in the rat mesenteric arterial bed.
    Westfall TC; Naes L; Gardner A; Yang CL
    J Cardiovasc Pharmacol; 2006 Jun; 47(6):723-8. PubMed ID: 16810071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuropeptide Y inhibits Ca2+ influx into cultured dorsal root ganglion neurones of the rat via a Y2 receptor.
    Bleakman D; Colmers WF; Fournier A; Miller RJ
    Br J Pharmacol; 1991 Jul; 103(3):1781-9. PubMed ID: 1718523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sympathetic regulation of skeletal muscle blood flow in the pig: a non-adrenergic component likely to be mediated by neuropeptide Y.
    Modin A; Pernow J; Lundberg JM
    Acta Physiol Scand; 1993 May; 148(1):1-11. PubMed ID: 8333291
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuropeptide Y regulates rat renal tubular Na,K-ATPase through several signalling pathways.
    Ohtomo Y; Ono S; Zettergren E; Sahlgren B
    Acta Physiol Scand; 1996 Sep; 158(1):97-105. PubMed ID: 8876753
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuropeptide Y modulates effects of bradykinin and prostaglandin E2 on trigeminal nociceptors via activation of the Y1 and Y2 receptors.
    Gibbs JL; Diogenes A; Hargreaves KM
    Br J Pharmacol; 2007 Jan; 150(1):72-9. PubMed ID: 17143304
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of K+ and Ca++ channels by a family of neuropeptide Y receptors.
    Sun L; Philipson LH; Miller RJ
    J Pharmacol Exp Ther; 1998 Feb; 284(2):625-32. PubMed ID: 9454807
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuropeptide Y inhibits [Ca2+]i changes in rat retinal neurons through NPY Y1, Y4, and Y5 receptors.
    Alvaro AR; Rosmaninho-Salgado J; Ambrósio AF; Cavadas C
    J Neurochem; 2009 Jun; 109(5):1508-15. PubMed ID: 19344373
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuropeptide Y suppresses absence seizures in a genetic rat model primarily through effects on Y receptors.
    Morris MJ; Gannan E; Stroud LM; Beck-Sickinger AG; O'Brien TJ
    Eur J Neurosci; 2007 Feb; 25(4):1136-43. PubMed ID: 17331209
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence that the inhibition of luteinizing hormone secretion exerted by central administration of neuropeptide Y (NPY) in the rat is predominantly mediated by the NPY-Y5 receptor subtype.
    Raposinho PD; Broqua P; Pierroz DD; Hayward A; Dumont Y; Quirion R; Junien JL; Aubert ML
    Endocrinology; 1999 Sep; 140(9):4046-55. PubMed ID: 10465275
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuropeptide Y suppresses epileptiform activity in rat hippocampus in vitro.
    Klapstein GJ; Colmers WF
    J Neurophysiol; 1997 Sep; 78(3):1651-61. PubMed ID: 9310450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.